Viewing Study NCT06386783



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06386783
Status: RECRUITING
Last Update Posted: 2024-05-03
First Post: 2024-04-04

Brief Title: Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia Peritoneal Symptomatic Effects
Sponsor: Aswan University
Organization: Aswan University

Study Overview

Official Title: Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anaesthesia for Appendectomy Patients Peritoneal Symptomatic Effects A Randomized Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To compare whether 5 μg dexmedetomidine with 25 μg fentanyl added to 05 hyperbaric bupivacaine as adjuvants in spinal anaesthesia in patients undergoing appendectomy could reduce intraoperative peritoneal related symptoms
Detailed Description: Acute appendicitis is among the most common causes of lower abdominal pain leading patients to attend the emergency department and the most common diagnosis made in young patients admitted to the hospital with an acute abdomen

In intracavitary abdominal surgery eg Appendectomygeneral anesthesia is conventionally chosen as it provides a higher safety profile with respect to the risk of aspiration abdominal discomfort and better exposure secondary to muscle relaxation however at present it is considered safe to do spinal anesthesia in various abdominal procedures even where significant muscle relaxation is required in certain complex cases such as peritonitis many patients with complicated conditions were operated under spinal anesthesia which did not significantly interfere with surgical technique or exposure Additional advantages of spinal anesthesia include faster recovery better oral tolerance and shorter hospital stay compared to general anesthesia

The Covid-19 pandemic currently affects almost every aspect of healthcare The risk to the operating room team from the contaminated aerosols produced by intubation and positive pressure ventilation may be reduced by performing suitable open operations with neuraxial anaesthesia instead of General anesthesia

Neuroaxial anesthesia is commonly preferred for surgeries of lower abdomen perineal and lower limb It is easy to administer and very economical but needs skills Intrathecal local anesthetics are limited by short duration of action and needs early use of rescue analgesia postoperatively Adjuvants are added to improve quality and duration provide better postoperative analgesia and patient comfort

A common problem during abdominal surgeries under spinal anesthesia is peritoneal related symptoms as visceral pain nausea vomiting vagal symptoms like bradycardia and hypotension

Many adjuvants like fentanyl morphine ketamine neostigmine and clonidine are being used to prolong the analgesic effects of local anaesthetic for many years These drugs including opioids are usually results in several side effects include itching decrease respiratory rate difficulty in urination postoperative gastrointestinal disturbance which can be overcome by preferring them as adjuvant with other analgesics

Intraoperative peritoneal related symptoms as visceral pain nausea vomiting vagal symptoms like bradycardia and hypotension are a common problem and there are some intrathecal adjuvants can solve these symptoms

Fentanyl is µ receptor agonist 80 times more potent than morphine as an analgesic added to spinal 05 heavy bupivacaine improves quality of spinal analgesia reduces visceral and somatic pain However their addition may have side effects like pruritus respiratory depression urinary retention postoperative nausea and vomiting which limits their use

Dexmedetomidine is highly selective α2-agonist S-enantiomer of veterinary sedative medetomidine Food and Drug Administration has approved its use for short-term ICU sedation it is reported to provide sedation that parallels natural sleep anxiolysis analgesia sympatholytic and anaesthetic-sparing effect with minimal respiratory depression α2- agonists produce clinical effects

It was reported in a previous study that intraoperative dexmedetomidine can reduce the incidence of postoperative nausea and vomiting PONVin patients undergoing thoracic surgery and a dose-response relationship between intraoperative dexmedetomidine and PONV was Observed and the optimal dose range for antiemetic effects of PONV is 50-100 μg Previous small Some meta-analyses demonstrated that intraoperative dexmedetomidine significantly lowered post-operative pain scores and opioid consumption which could lead to a reduced opioid-related adverse events including PONV

Dexmedetomidine prevents and reduces peritoneal related symptoms Intraoperative and it can significantly lower the demand for opioids and inhalation anesthesia during and after operation which could help to reduce opioid-related adverse events including PONV

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None